MARKET HARBOROUGH MED.CTR — All Prescriptions & Medications — Page 17
Practice Code: C82009 | MARKET HARBOROUGH, LE16 9BX
Showing results 801-850 of 866
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hyoscine | 12 | 55 | £354 | +72.9% ▲ |
| Stiripentol | 12 | 740 | £3.6K | +0.1% vs avg |
| Dexamethasone phosphate | 12 | 170 | £199 | +163.1% ▲ |
| Other health supplement preparations | 12 | 360 | £43 | -74.7% ▼ |
| Ready to serve 1.5 kcal/ml milkshake (0913021) | 12 | 33.6K | £806 | +12.5% ▲ |
| Powder fibre fortifier (0913151) | 12 | 3,250 | £170 | +54.4% ▲ |
| Tube feed 1 kcal/ml with fibre (0914011) | 12 | 168.0K | £2.7K | +16.3% ▲ |
| Tube feed additive 0.5 kcal/ml high fibre liquid (0914052) | 12 | 3,872 | £457 | +24.5% ▲ |
| Hydrocortisone butyrate | 12 | 1,200 | £58 | +81.2% ▲ |
| Eflornithine monohydrate chloride | 12 | 720 | £648 | +70.8% ▲ |
| 12 | 600 | £116 | -18.3% ▼ | |
| 12 | 105 | £190 | +104.1% ▲ | |
| 12 | 12 | £198 | +39.7% ▲ | |
| 12 | 36 | £1.4K | +31.7% ▲ | |
| 12 | 130 | £376 | +90.2% ▲ | |
| 12 | 600 | £557 | +125.0% ▲ | |
| 12 | 36 | £490 | +408.5% ▲ | |
| 12 | 36 | £652 | +326.8% ▲ | |
| 12 | 360 | £1.1K | +4.8% ▲ | |
| 12 | 36 | £1.3K | +180.0% ▲ | |
| Lidocaine hydrochloride | 11 | 304 | £44 | +139.8% ▲ |
| Co-tenidone (Atenolol/chlortalidone) | 11 | 476 | £70 | -47.3% ▼ |
| Fluvoxamine maleate | 11 | 312 | £109 | -9.5% ▼ |
| Frovatriptan | 11 | 68 | £177 | -22.2% ▼ |
| Naltrexone hydrochloride | 11 | 252 | £625 | -22.5% ▼ |
| Valaciclovir | 11 | 386 | £647 | -21.7% ▼ |
| Clindamycin phosphate | 11 | 480 | £123 | +163.7% ▲ |
| Phentolamine/aviptadil | 11 | 54 | £460 | +54.1% ▲ |
| Iron and folic acid | 11 | 360 | £30 | +38.8% ▲ |
| Riboflavin | 11 | 25.3K | £1.0K | +19.0% ▲ |
| Vitamins caps | 11 | 660 | £12 | -80.0% ▼ |
| 11 | 362.2K | £5.8K | +21.3% ▲ | |
| Tube feed 1.3 kcal/ml peptide based (0914032) | 11 | 62.5K | £1.3K | +25.7% ▲ |
| Levobunolol hydrochloride | 11 | 600 | £180 | +51.5% ▲ |
| Salicylic acid | 11 | 93 | £39 | -13.0% ▼ |
| Other preparations | 11 | 330 | £115 | +13.7% ▲ |
| 11 | 105 | £162 | +10.9% ▲ | |
| 11 | 200 | £370 | -7.2% ▼ | |
| 11 | 33 | £184 | -13.5% ▼ | |
| 11 | 16 | £114 | +8.4% ▲ | |
| 11 | 13 | £1.1K | +33.6% ▲ | |
| 11 | 580 | £188 | -43.1% ▼ | |
| 11 | 780 | £567 | +52.1% ▲ | |
| 11 | 5,760 | £220 | +22.3% ▲ | |
| 11 | 225 | £832 | +43.9% ▲ | |
| Pimozide | 10 | 140 | £55 | +106.3% ▲ |
| Sulpiride | 10 | 300 | £25 | -62.7% ▼ |
| Clindamycin hydrochloride | 10 | 436 | £81 | -0.1% vs avg |
| Ivermectin | 10 | 56 | £680 | +2.5% ▲ |
| Darbepoetin alfa | 10 | 36 | £1.1K | +46.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.